109 related articles for article (PubMed ID: 21602032)
1. Transgenic rescue of desmoglein 3 null mice with desmoglein 1 to develop a syngeneic mouse model for pemphigus vulgaris.
Hata T; Nishifuji K; Shimoda K; Sasaki T; Yamada T; Nishikawa T; Koyasu S; Amagai M
J Dermatol Sci; 2011 Jul; 63(1):33-9. PubMed ID: 21602032
[TBL] [Abstract][Full Text] [Related]
2. A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice.
Aoki-Ota M; Tsunoda K; Ota T; Iwasaki T; Koyasu S; Amagai M; Nishikawa T
Br J Dermatol; 2004 Aug; 151(2):346-54. PubMed ID: 15327541
[TBL] [Abstract][Full Text] [Related]
3. Conformational epitope mapping of antibodies against desmoglein 3 in experimental murine pemphigus vulgaris.
Anzai H; Fujii Y; Nishifuji K; Aoki-Ota M; Ota T; Amagai M; Nishikawa T
J Dermatol Sci; 2004 Aug; 35(2):133-42. PubMed ID: 15265525
[TBL] [Abstract][Full Text] [Related]
4. Confirmation of a disease model of pemphigus vulgaris: characterization and correlation between disease parameters in 90 mice.
Holm TL; Markholst H
Exp Dermatol; 2010 Aug; 19(8):e158-65. PubMed ID: 20201956
[TBL] [Abstract][Full Text] [Related]
5. Subcellular localization of desmosomal components is different between desmoglein3 knockout mice and pemphigus vulgaris model mice.
Saito H; Shimizu A; Tsunoda K; Amagai M; Ishiko A
J Dermatol Sci; 2009 Aug; 55(2):108-15. PubMed ID: 19525093
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic autoantibody production requires loss of tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris.
Tsunoda K; Ota T; Suzuki H; Ohyama M; Nagai T; Nishikawa T; Amagai M; Koyasu S
Eur J Immunol; 2002 Mar; 32(3):627-33. PubMed ID: 11857336
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural changes in mice actively producing antibodies to desmoglein 3 parallel those in patients with pemphigus vulgaris.
Shimizu A; Ishiko A; Ota T; Tsunoda K; Koyasu S; Amagai M; Nishikawa T
Arch Dermatol Res; 2002 Oct; 294(7):318-23. PubMed ID: 12373337
[TBL] [Abstract][Full Text] [Related]
8. Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus.
Amagai M; Tsunoda K; Suzuki H; Nishifuji K; Koyasu S; Nishikawa T
J Clin Invest; 2000 Mar; 105(5):625-31. PubMed ID: 10712434
[TBL] [Abstract][Full Text] [Related]
9. Pemphigus vulgaris and its active disease mouse model.
Amagai M
Curr Dir Autoimmun; 2008; 10():167-81. PubMed ID: 18460885
[TBL] [Abstract][Full Text] [Related]
10. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
[TBL] [Abstract][Full Text] [Related]
11. Expression of desmoglein 1 compensates for genetic loss of desmoglein 3 in keratinocyte adhesion.
Hanakawa Y; Matsuyoshi N; Stanley JR
J Invest Dermatol; 2002 Jul; 119(1):27-31. PubMed ID: 12164920
[TBL] [Abstract][Full Text] [Related]
12. Pemphigus mouse model as a tool to evaluate various immunosuppressive therapies.
Takae Y; Nishikawa T; Amagai M
Exp Dermatol; 2009 Mar; 18(3):252-60. PubMed ID: 18643850
[TBL] [Abstract][Full Text] [Related]
13. Antigen-independent development of Foxp3+ regulatory T cells suppressing autoantibody production in experimental pemphigus vulgaris.
Yokoyama T; Matsuda S; Takae Y; Wada N; Nishikawa T; Amagai M; Koyasu S
Int Immunol; 2011 Jun; 23(6):365-73. PubMed ID: 21525154
[TBL] [Abstract][Full Text] [Related]
14. Aire-dependent thymic expression of desmoglein 3, the autoantigen in pemphigus vulgaris, and its role in T-cell tolerance.
Wada N; Nishifuji K; Yamada T; Kudoh J; Shimizu N; Matsumoto M; Peltonen L; Nagafuchi S; Amagai M
J Invest Dermatol; 2011 Feb; 131(2):410-7. PubMed ID: 21048786
[TBL] [Abstract][Full Text] [Related]
15. Desmoglein 3-specific CD4+ T cells induce pemphigus vulgaris and interface dermatitis in mice.
Takahashi H; Kouno M; Nagao K; Wada N; Hata T; Nishimoto S; Iwakura Y; Yoshimura A; Yamada T; Kuwana M; Fujii H; Koyasu S; Amagai M
J Clin Invest; 2011 Sep; 121(9):3677-88. PubMed ID: 21821914
[TBL] [Abstract][Full Text] [Related]
16. Mucosal pemphigus vulgaris anti-Dsg3 IgG is pathogenic to the oral mucosa of humanized Dsg3 mice.
Culton DA; McCray SK; Park M; Roberts JC; Li N; Zedek DC; Anhalt GJ; Cowley DO; Liu Z; Diaz LA
J Invest Dermatol; 2015 Jun; 135(6):1590-1597. PubMed ID: 25695683
[TBL] [Abstract][Full Text] [Related]
17. Ectopic expression of epidermal antigens renders the lung a target organ in paraneoplastic pemphigus.
Hata T; Nishimoto S; Nagao K; Takahashi H; Yoshida K; Ohyama M; Yamada T; Asano K; Amagai M
J Immunol; 2013 Jul; 191(1):83-90. PubMed ID: 23729442
[TBL] [Abstract][Full Text] [Related]
18. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
[TBL] [Abstract][Full Text] [Related]
19. Immunologic and histopathologic characterization of an active disease mouse model for pemphigus vulgaris.
Ohyama M; Amagai M; Tsunoda K; Ota T; Koyasu S; Hata J; Umezawa A; Nishikawa T
J Invest Dermatol; 2002 Jan; 118(1):199-204. PubMed ID: 11851895
[TBL] [Abstract][Full Text] [Related]
20. Tolerance induction by the blockade of CD40/CD154 interaction in pemphigus vulgaris mouse model.
Aoki-Ota M; Kinoshita M; Ota T; Tsunoda K; Iwasaki T; Tanaka S; Koyasu S; Nishikawa T; Amagai M
J Invest Dermatol; 2006 Jan; 126(1):105-13. PubMed ID: 16417225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
